Srs Capital Advisors, Inc. Lannett CO Inc Transaction History

Srs Capital Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 06, 2018	SELL	$4.75 - $14.5 $2,436 - $7,438	-513 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$19.9 - $29.25 $324,768 - $477,360	-16,320 Reduced 96.95%	513 $11,000
Q3 2017 Nov 15, 2017	BUY	$15.1 - $19.25 $254,178 - $324,035	16,833	16,833 $310,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Srs Capital Advisors, Inc. with notifications on news.